BackAntares Pharma Overview

Antares Pharma Total Revenue

Revenue analysis for ATRS.

Quarterly Revenue

$41.56M
↓ 1.25% YoY

As of Mar 2022

Annual Revenue (TTM)

$183.46M
↑ 15.67% YoY

Trailing 12 months ending Mar 2022

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin